000 | 01863 a2200481 4500 | ||
---|---|---|---|
005 | 20250517000253.0 | ||
264 | 0 | _c20150413 | |
008 | 201504s 0 0 eng d | ||
022 | _a1678-2674 | ||
024 | 7 |
_a10.1590/s0102-8650201400160001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPortinho, Ciro Paz | |
245 | 0 | 0 |
_aCranial vault reconstruction with bone morphogenetic protein, calcium phosphate, acellular dermal matrix, and calcium alginate in mice. _h[electronic resource] |
260 |
_bActa cirurgica brasileira _cOct 2014 |
||
300 |
_a622-32 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcellular Dermis |
650 | 0 | 4 |
_aAlginates _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiocompatible Materials _xtherapeutic use |
650 | 0 | 4 |
_aBone Morphogenetic Protein 2 _xtherapeutic use |
650 | 0 | 4 |
_aBone Regeneration _xdrug effects |
650 | 0 | 4 |
_aBone Substitutes _xtherapeutic use |
650 | 0 | 4 |
_aBone Transplantation _xmethods |
650 | 0 | 4 |
_aCalcium Phosphates _xtherapeutic use |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGlucuronic Acid _xtherapeutic use |
650 | 0 | 4 |
_aHexuronic Acids _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 |
_aSkull _xpathology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSantos, Luís Alberto | |
700 | 1 | _aCerski, Thadeu | |
700 | 1 | _aRivero, Raquel Camara | |
700 | 1 | _aCollares, Marcus Vinícius Martins | |
773 | 0 |
_tActa cirurgica brasileira _gvol. 29 _gno. 10 _gp. 622-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1590/s0102-8650201400160001 _zAvailable from publisher's website |
999 |
_c24281046 _d24281046 |